This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ahead Of The Bell: Express Scripts Plummets

NEW YORK (AP) â¿¿ Shares of Express Scripts slid in premarket trading Tuesday after the pharmacy benefits manager warned that persistent high joblessness and economic uncertainty would make 2013 more challenging, and expectations of Wall Street analysts were too high.

Pharmacy benefits managers, or PBMs, run prescription drug plans for employers, insurers and other customers. They process mail-order prescriptions and handle bills for prescriptions filled at retail pharmacies.

The St. Louis company handles more than a billion prescriptions each year after the $29.1 billion acquisition of a rival, Medco, in April.

Analysts were disappointed by the company's outlook. Investors will now question whether Express Scripts benefits as much from recent acquisitions as the company had led them to believe, said Citi analyst George Hill, calling the company's forecast "baffling."

Express Scripts had lifted its 2012 earnings forecast in August after recording better-than-expected savings from its combination with Medco.

Jefferies analyst Brian Tanquilut lowered his rating on Express Scripts to "Hold" from "Buy" and cut his price target on the shares by $14 to $56.

Shares of Express Scripts Holding Co. dropped $8.25, or 13 percent, to $54.63 before the opening bell. The stock was up 41 percent so far this year through Monday's trading.
Copyright 2011 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,751.39 +121.12 0.69%
S&P 500 2,108.57 +15.32 0.73%
NASDAQ 5,111.7330 +22.5270 0.44%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs